High doses of statins can cause kidney damage

Image
Press Trust of India London
Last Updated : Mar 20 2013 | 5:50 PM IST
High doses of statins, a drug prescribed to lower cholesterol, could dramatically increase the risk of kidney damage, a new study has warned.
Researchers from University of British Columbia and the Lady Davis Institute at the Jewish General Hospital in Montreal studied more than two million statin users.
They found that patients taking higher strength pills were more at risk of suffering acute kidney injury.
They were at a 34 per cent greater danger of being hospitalised with kidney problems within 120 days of starting treatment with high-dose statins than low-dose pills, the Daily Express reported.
"In some cases, patients may be exposed to unnecessary risk of kidney damage for small gains in cardiovascular health. Although the absolute risk of kidney damage with these drugs is low, our findings put into question the common approach of using higher doses to push cholesterol levels lower and lower," author of the Canadian report, Professor Colin Dormuth, said.
About one in 500 patients were hospitalised for acute kidney injury within a period of up to two years - the length of the study - after starting a lower strength statin, according to study published in British Medical Journal.
"We are not saying don't take statins. If you are giving patients a high dose statin, let's make sure there is a good reason. A high dose might be beneficial for those who have had a heart attack or have high cholesterol, and then they are life-saving," said Dr Pierre Ernst, professor of medicine at the McGill University Centre for Clinical Epidemiology in Montreal, who was involved in the research.
"But for the 40-year-old woman who exercises, doesn't have high blood pressure and only slightly raised cholesterol, there is no need to put her on a high dose," Ernst said.
Statins considered to be high potency were rosuvastatin at doses of 10mg or higher, atorvastatin at doses of 20mg or higher, and simvastatin at doses of 40mg or more.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 20 2013 | 5:50 PM IST

Next Story